Rolph Timothy's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed Jul 9, 2025
- Accession no.
- 0000950170-25-094882
- Filed
- Jul 9, 2025
- Trade date
- Jul 7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $638.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rolph TimothyCIK 0001779479 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Common Stock | MOption exerciseAcquired | +12,500 | $21.09 | +$263,625 | 179,624 | Direct | |
| Jul 7, 2025 | Common Stock | SSaleDisposed | −10,634 | $50.93 | −$541,589.62 | 168,990 | Direct | |
| Jul 7, 2025 | Common Stock | SSaleDisposed | −1,825 | $52.00 | −$94,900 | 167,165 | Direct | |
| Jul 7, 2025 | Common Stock | SSaleDisposed | −41 | $52.62 | −$2,157.42 | 167,124 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 19,933 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.